Deuterium-substituteddrugs Market - Global Outlook and Forecast 2022-2028

February 2022 | 62 pages | ID: D0B5EC8E0252EN
Market Monitor Global

Abstracts

Deuterium is the replacement of hydrogen atoms with deuterium atoms in one or more of the c-h bonds in a compound molecule.

This report contains market size and forecasts of Deuterium-substituteddrugs in Global, including the following market information:

Global Deuterium-substituteddrugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Deuterium-substituteddrugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drugs in Clinical Trials Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Deuterium-substituteddrugs include Teva, Bristol-Myers Squibb, Retrotope, Alkeus, Avanir, Concert, Processa, Vertex and Jazz Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Deuterium-substituteddrugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Deuterium-substituteddrugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Deuterium-substituteddrugs Market Segment Percentages, by Type, 2021 (%)

• Drugs in Clinical Trials
• Marketed Drug

Global Deuterium-substituteddrugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Deuterium-substituteddrugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Deuterium-substituteddrugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Deuterium-substituteddrugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Deuterium-substituteddrugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Deuterium-substituteddrugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva
• Bristol-Myers Squibb
• Retrotope
• Alkeus
• Avanir
• Concert
• Processa
• Vertex
• Jazz Pharmaceuticals
• Zelgen
• Hinova Pharmaceuticals Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Deuterium-substituteddrugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Deuterium-substituteddrugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DEUTERIUM-SUBSTITUTEDDRUGS OVERALL MARKET SIZE

2.1 Global Deuterium-substituteddrugs Market Size: 2021 VS 2028
2.2 Global Deuterium-substituteddrugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Deuterium-substituteddrugs Players in Global Market
3.2 Top Global Deuterium-substituteddrugs Companies Ranked by Revenue
3.3 Global Deuterium-substituteddrugs Revenue by Companies
3.4 Top 3 and Top 5 Deuterium-substituteddrugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Deuterium-substituteddrugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Deuterium-substituteddrugs Players in Global Market
  3.6.1 List of Global Tier 1 Deuterium-substituteddrugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Deuterium-substituteddrugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Deuterium-substituteddrugs Market Size Markets, 2021 & 2028
  4.1.2 Drugs in Clinical Trials
  4.1.3 Marketed Drug
4.2 By Type - Global Deuterium-substituteddrugs Revenue & Forecasts
  4.2.1 By Type - Global Deuterium-substituteddrugs Revenue, 2017-2022
  4.2.2 By Type - Global Deuterium-substituteddrugs Revenue, 2023-2028
  4.2.3 By Type - Global Deuterium-substituteddrugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Deuterium-substituteddrugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Deuterium-substituteddrugs Revenue & Forecasts
  5.2.1 By Application - Global Deuterium-substituteddrugs Revenue, 2017-2022
  5.2.2 By Application - Global Deuterium-substituteddrugs Revenue, 2023-2028
  5.2.3 By Application - Global Deuterium-substituteddrugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Deuterium-substituteddrugs Market Size, 2021 & 2028
6.2 By Region - Global Deuterium-substituteddrugs Revenue & Forecasts
  6.2.1 By Region - Global Deuterium-substituteddrugs Revenue, 2017-2022
  6.2.2 By Region - Global Deuterium-substituteddrugs Revenue, 2023-2028
  6.2.3 By Region - Global Deuterium-substituteddrugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Deuterium-substituteddrugs Revenue, 2017-2028
  6.3.2 US Deuterium-substituteddrugs Market Size, 2017-2028
  6.3.3 Canada Deuterium-substituteddrugs Market Size, 2017-2028
  6.3.4 Mexico Deuterium-substituteddrugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Deuterium-substituteddrugs Revenue, 2017-2028
  6.4.2 Germany Deuterium-substituteddrugs Market Size, 2017-2028
  6.4.3 France Deuterium-substituteddrugs Market Size, 2017-2028
  6.4.4 U.K. Deuterium-substituteddrugs Market Size, 2017-2028
  6.4.5 Italy Deuterium-substituteddrugs Market Size, 2017-2028
  6.4.6 Russia Deuterium-substituteddrugs Market Size, 2017-2028
  6.4.7 Nordic Countries Deuterium-substituteddrugs Market Size, 2017-2028
  6.4.8 Benelux Deuterium-substituteddrugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Deuterium-substituteddrugs Revenue, 2017-2028
  6.5.2 China Deuterium-substituteddrugs Market Size, 2017-2028
  6.5.3 Japan Deuterium-substituteddrugs Market Size, 2017-2028
  6.5.4 South Korea Deuterium-substituteddrugs Market Size, 2017-2028
  6.5.5 Southeast Asia Deuterium-substituteddrugs Market Size, 2017-2028
  6.5.6 India Deuterium-substituteddrugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Deuterium-substituteddrugs Revenue, 2017-2028
  6.6.2 Brazil Deuterium-substituteddrugs Market Size, 2017-2028
  6.6.3 Argentina Deuterium-substituteddrugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Deuterium-substituteddrugs Revenue, 2017-2028
  6.7.2 Turkey Deuterium-substituteddrugs Market Size, 2017-2028
  6.7.3 Israel Deuterium-substituteddrugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Deuterium-substituteddrugs Market Size, 2017-2028
  6.7.5 UAE Deuterium-substituteddrugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva
  7.1.1 Teva Corporate Summary
  7.1.2 Teva Business Overview
  7.1.3 Teva Deuterium-substituteddrugs Major Product Offerings
  7.1.4 Teva Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.1.5 Teva Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Deuterium-substituteddrugs Major Product Offerings
  7.2.4 Bristol-Myers Squibb Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Retrotope
  7.3.1 Retrotope Corporate Summary
  7.3.2 Retrotope Business Overview
  7.3.3 Retrotope Deuterium-substituteddrugs Major Product Offerings
  7.3.4 Retrotope Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.3.5 Retrotope Key News
7.4 Alkeus
  7.4.1 Alkeus Corporate Summary
  7.4.2 Alkeus Business Overview
  7.4.3 Alkeus Deuterium-substituteddrugs Major Product Offerings
  7.4.4 Alkeus Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.4.5 Alkeus Key News
7.5 Avanir
  7.5.1 Avanir Corporate Summary
  7.5.2 Avanir Business Overview
  7.5.3 Avanir Deuterium-substituteddrugs Major Product Offerings
  7.5.4 Avanir Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.5.5 Avanir Key News
7.6 Concert
  7.6.1 Concert Corporate Summary
  7.6.2 Concert Business Overview
  7.6.3 Concert Deuterium-substituteddrugs Major Product Offerings
  7.6.4 Concert Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.6.5 Concert Key News
7.7 Processa
  7.7.1 Processa Corporate Summary
  7.7.2 Processa Business Overview
  7.7.3 Processa Deuterium-substituteddrugs Major Product Offerings
  7.7.4 Processa Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.7.5 Processa Key News
7.8 Vertex
  7.8.1 Vertex Corporate Summary
  7.8.2 Vertex Business Overview
  7.8.3 Vertex Deuterium-substituteddrugs Major Product Offerings
  7.8.4 Vertex Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.8.5 Vertex Key News
7.9 Jazz Pharmaceuticals
  7.9.1 Jazz Pharmaceuticals Corporate Summary
  7.9.2 Jazz Pharmaceuticals Business Overview
  7.9.3 Jazz Pharmaceuticals Deuterium-substituteddrugs Major Product Offerings
  7.9.4 Jazz Pharmaceuticals Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.9.5 Jazz Pharmaceuticals Key News
7.10 Zelgen
  7.10.1 Zelgen Corporate Summary
  7.10.2 Zelgen Business Overview
  7.10.3 Zelgen Deuterium-substituteddrugs Major Product Offerings
  7.10.4 Zelgen Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.10.5 Zelgen Key News
7.11 Hinova Pharmaceuticals Inc.
  7.11.1 Hinova Pharmaceuticals Inc. Corporate Summary
  7.11.2 Hinova Pharmaceuticals Inc. Business Overview
  7.11.3 Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Major Product Offerings
  7.11.4 Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Revenue in Global Market (2017-2022)
  7.11.5 Hinova Pharmaceuticals Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Deuterium-substituteddrugs Market Opportunities & Trends in Global Market
Table 2. Deuterium-substituteddrugs Market Drivers in Global Market
Table 3. Deuterium-substituteddrugs Market Restraints in Global Market
Table 4. Key Players of Deuterium-substituteddrugs in Global Market
Table 5. Top Deuterium-substituteddrugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Deuterium-substituteddrugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Deuterium-substituteddrugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Deuterium-substituteddrugs Product Type
Table 9. List of Global Tier 1 Deuterium-substituteddrugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Deuterium-substituteddrugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Deuterium-substituteddrugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Deuterium-substituteddrugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Deuterium-substituteddrugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Deuterium-substituteddrugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Deuterium-substituteddrugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Deuterium-substituteddrugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Deuterium-substituteddrugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Deuterium-substituteddrugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Deuterium-substituteddrugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Deuterium-substituteddrugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Deuterium-substituteddrugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Deuterium-substituteddrugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Deuterium-substituteddrugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Deuterium-substituteddrugs Revenue, (US$, Mn), 2023-2028
Table 30. Teva Corporate Summary
Table 31. Teva Deuterium-substituteddrugs Product Offerings
Table 32. Teva Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Deuterium-substituteddrugs Product Offerings
Table 35. Bristol-Myers Squibb Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)
Table 36. Retrotope Corporate Summary
Table 37. Retrotope Deuterium-substituteddrugs Product Offerings
Table 38. Retrotope Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)
Table 39. Alkeus Corporate Summary
Table 40. Alkeus Deuterium-substituteddrugs Product Offerings
Table 41. Alkeus Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)
Table 42. Avanir Corporate Summary
Table 43. Avanir Deuterium-substituteddrugs Product Offerings
Table 44. Avanir Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)
Table 45. Concert Corporate Summary
Table 46. Concert Deuterium-substituteddrugs Product Offerings
Table 47. Concert Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)
Table 48. Processa Corporate Summary
Table 49. Processa Deuterium-substituteddrugs Product Offerings
Table 50. Processa Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)
Table 51. Vertex Corporate Summary
Table 52. Vertex Deuterium-substituteddrugs Product Offerings
Table 53. Vertex Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)
Table 54. Jazz Pharmaceuticals Corporate Summary
Table 55. Jazz Pharmaceuticals Deuterium-substituteddrugs Product Offerings
Table 56. Jazz Pharmaceuticals Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)
Table 57. Zelgen Corporate Summary
Table 58. Zelgen Deuterium-substituteddrugs Product Offerings
Table 59. Zelgen Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)
Table 60. Hinova Pharmaceuticals Inc. Corporate Summary
Table 61. Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Product Offerings
Table 62. Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Deuterium-substituteddrugs Segment by Type in 2021
Figure 2. Deuterium-substituteddrugs Segment by Application in 2021
Figure 3. Global Deuterium-substituteddrugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Deuterium-substituteddrugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Deuterium-substituteddrugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Deuterium-substituteddrugs Revenue in 2021
Figure 8. By Type - Global Deuterium-substituteddrugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Deuterium-substituteddrugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Deuterium-substituteddrugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Deuterium-substituteddrugs Revenue Market Share, 2017-2028
Figure 12. US Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Deuterium-substituteddrugs Revenue Market Share, 2017-2028
Figure 16. Germany Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Deuterium-substituteddrugs Revenue Market Share, 2017-2028
Figure 24. China Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Deuterium-substituteddrugs Revenue Market Share, 2017-2028
Figure 30. Brazil Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Deuterium-substituteddrugs Revenue Market Share, 2017-2028
Figure 33. Turkey Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Deuterium-substituteddrugs Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Retrotope Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Alkeus Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Avanir Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Concert Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Processa Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Vertex Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Jazz Pharmaceuticals Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zelgen Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)